{"id":1025132,"date":"2026-08-26T11:35:15","date_gmt":"2026-08-26T11:35:15","guid":{"rendered":"https:\/\/www.europesays.com\/us\/1025132\/"},"modified":"2026-08-26T11:35:15","modified_gmt":"2026-08-26T11:35:15","slug":"uk-supplements-industry-urged-to-improve-vitamin-b12-awareness","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/1025132\/","title":{"rendered":"UK supplements industry urged to improve vitamin B12 awareness"},"content":{"rendered":"

Formed in 2023 by patient organisations and healthcare professionals, the not-for-profit alliance aims to give people affected by B12 deficiency a stronger collective voice. <\/p>\n

At a House of Commons reception in Westminster next month, the alliance will bring together parliamentarians, clinicians and patient advocates to discuss ongoing challenges surrounding the condition.<\/p>\n

Dr Harry Jarrett, director of science and research at UK supplement brand Heights and member of the B-12 Alliance group, said the event will serve to highlight that B12 deficiency is a public health issue that needs to be tackled from all angles.<\/p>\n

\u201cThe event is a reminder that the credible path for industry runs alongside clinicians, patient groups and academics,\u201d Jarrett told NutraIngredients.<\/p>\n

A recent study<\/a> from Heights found that 34% of apparently healthy adults were deficient in vitamin B12. The 12-week trial, conducted with the Functional Gut Clinic and King\u2019s College London, also found that participants taking Heights\u2019 Vitals multivitamin increased their active B12 levels by 25%, alongside improvements in other nutrient biomarkers.<\/p>\n

\"HeightsA UK-based clinical trial led by researchers from Heights, King\u2019s College London, and the Functional Gut Clinic investigated whether targeted multivitamin supplementation can correct widespread micronutrient deficiencies in apparently healthy adults. (Heights)B12 awareness gap persists in the UK<\/p>\n

People following plant-based diets, older adults and those taking long-term medications such as metformin or acid-suppressing drugs are the most at risk of deficiency, Jarrett noted.<\/p>\n

\u201cTargeting these groups, improving their vitamin B12 levels could have real-world impact,\u201d he said.<\/p>\n

B12 deficiency remains poorly understood and diagnosed in the UK for multiple reasons. It can cause non-specific symptoms such as fatigue, brain fog, low mood, memory problems and tingling, all of which can be put down to stress, ageing or \u2018a dozen other conditions long before anyone thinks to check B12\u2019, Jarrett said.<\/p>\n

Furthermore, standard B12 testing has limitations and may not always reflect a person\u2019s true status; plus, the condition spans several medical specialities, making it easy to overlook.<\/p>\n

\u201cWe now have clear National Institute for Health and Care Excellence guidance, which is a real step forward, but guidance only helps once awareness catches up with it, and that is the gap we are still closing and the aim of this important parliamentary event,\u201d he said.<\/p>\n

Industry urged to improve consumer awareness<\/p>\n

There is a real opportunity for B12 supplementation and fortified foods to support prevention, Jarrett noted, particularly among at-risk groups.<\/p>\n

\u201cThe prevention case isn\u2019t only theoretical either: a well-formulated, trusted supplement can measurably improve people\u2019s B12 status, which is something we\u2019ve seen in our own trial,\u201d Jarrett noted.<\/p>\n

However, he stressed that clear and honest communication is essential. Supplementation and fortification can help address dietary insufficiency and support prevention, but should not be positioned as a substitute for medical treatment.<\/p>\n

\u201cWe could do a far better job of explaining who is actually at risk and what the early signs look like, without tipping into scaremongering,\u201d Jarrett said. \u201cLabeling could be much clearer on the different forms of B12, sensible doses and who genuinely benefits.\u201d<\/p>\n

Keeping that distinction clear is important for the supplements industry, as it builds consumer trust, avoids over-claiming and allows the sector to make a credible case for supplementation where it can genuinely support dietary needs and prevention, Jarrett argued.<\/p>\n

\u201cFor the industry, there is a clear and legitimate role, provided we play it responsibly,\u201d Jarrett said. \u201cWe can help raise awareness, support earlier identification and signpost people towards testing and clinical care rather than around it. Where we add the most value is by leading on evidence.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"Formed in 2023 by patient organisations and healthcare professionals, the not-for-profit alliance aims to give people affected by…\n","protected":false},"author":3,"featured_media":1025133,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[37],"tags":[410115,210,1182,24755,67,132,68,410116],"class_list":["post-1025132","post","type-post","status-publish","format-standard","has-post-thumbnail","category-nutrition","tag-binary-shoot","tag-health","tag-nutrition","tag-pill","tag-united-states","tag-unitedstates","tag-us","tag-vitals"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/117161605905431739","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/1025132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=1025132"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/1025132\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/1025133"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=1025132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=1025132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=1025132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}